Seattle, WA, United States of America

John Steven Whitaker

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: John Steven Whitaker: Innovator in Antibody Formulations

Introduction

John Steven Whitaker is a notable inventor based in Seattle, WA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibody formulations. His work focuses on enhancing therapeutic methods to inhibit adverse effects related to complement activation.

Latest Patents

Whitaker holds a patent for "Highly concentrated low viscosity MASP-2 inhibitory antibody formulations, kits, and methods." This invention relates to stable, high-concentration low-viscosity formulations of MASP-2 inhibitory antibodies. The patent also includes kits comprising these formulations and therapeutic methods for using them to inhibit the adverse effects of MASP-2 dependent complement activation. He has 1 patent to his name.

Career Highlights

Whitaker is currently associated with Omeros Corporation, where he continues to innovate in the field of antibody research. His work has the potential to significantly impact therapeutic approaches in medicine.

Collaborations

Some of his notable coworkers include Gregory A Demopulos and Kenneth M Ferguson. Their collaboration contributes to the advancement of research and development in the biotechnology sector.

Conclusion

John Steven Whitaker's contributions to antibody formulations exemplify the innovative spirit in biotechnology. His work not only enhances therapeutic methods but also showcases the importance of collaboration in scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…